Spectral Properties and Basicity of Stilbazolium Betaines Containing Bulky Substituents on the Quinoid Ring

DOI: 10.1021/jo00192a010

Source and publish data:

Journal of Organic Chemistry p. 3300 - 3305 (1984)

Update date:2022-08-04

Topics:

Authors:

Gruda, Ilona

Bolduc, Francois

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/jo00192a010

Several derivatives of 4-<(4-oxocyclohexa-2,5-dienylidene)ethylidene>-1,4-dihydropyridine were synthesized.The effect of bulky substituents in the immediate vicinity of carbonyl on the basicity and visible spectra of these compouds is described.The basici

Full text of DOI:10.1021/jo00192a010

Products guided by the article

Product name:2,5-Cyclohexadien-1-one, 4-[[1-(6-hydroxyhexyl)-4(1H)-pyridinylidene]ethylidene]-2,6-dimethyl-

Cas No:91178-49-3

R&D Labs maybe for 91178-49-3

YanCheng LongShen Chemical Co.,Ltd.

Contact:+86-515-86668866

Address:No.13,Weiyi Road,Funing Aoyang Industrial Park
Jinan Trio PharmaTech Co., Ltd

Contact:86-531-88811783；+(0)13153010282

Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
Hangzhou Share Chemical Co., Ltd(expird)

Contact:+86-57187093700

Address:Hang Xing Road
Nanjing Legend Pharmaceutical & Chemical Co., Ltd.

Contact:+86-25-83767696

Address:14-7 Zhongshan Lu Guluo District, Nanjing
ANTAI BIO-TECH CO LTD

website:http://www.antaibio.com

Contact:0086-21-65663057

Address:Room 2108, Building 2，No. 489 Zhengli Road，200433

Relevant to this article

Doi:10.1007/BF00509798
()
Synthesis and Biological of Flavipucine Analogues

Doi:10.1021/jm00176a019
(1980)
High-Throughput Screening and Hit Validation of Extracellular-Related Kinase 5 (ERK5) Inhibitors

Doi:10.1021/acscombsci.5b00155
(2016)
Doi:10.1021/ja01578a033
(1957)
Activation and inhibition of leukotriene A₄ hydrolase aminopeptidase activity by diphenyl ether and derivatives

Doi:10.1016/j.bmcl.2008.10.044
(2008)
Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease

Doi:10.1016/j.bmc.2017.03.070
(2017)

Article Doi